Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Circulating tumor DNA analysis to assess risk of progression after long-term response to PD-(L)1 blockade in NSCLC.

Hellmann MD, Nabet BY, Rizvi H, Chaudhuri AA, Wells DK, Dunphy MP, Chabon JJ, Liu CL, Hui AB, Arbour KC, Luo J, Preeshagul IR, Moding EJ, Almanza D, Bonilla RF, Sauter JL, Choi H, Tenet M, Abu-Akeel M, Plodkowski AJ, Perez-Johnston R, Yoo CH, Ko RB, Stehr H, Gojenola L, Wakelee HA, Padda SK, Neal JW, Chaft JE, Kris MG, Rudin CM, Merghoub T, Li BT, Alizadeh AA, Diehn M.

Clin Cancer Res. 2020 Feb 11. pii: clincanres.3418.2019. doi: 10.1158/1078-0432.CCR-19-3418. [Epub ahead of print]

PMID:
32046999
2.

Predictors of Respiratory Decline Following Stereotactic Ablative Radiotherapy to Multiple Lung Tumors.

Moding EJ, Liang R, Lartey FM, Maxim PG, Sung A, Diehn M, Loo BW Jr, Gensheimer MF.

Clin Lung Cancer. 2019 Nov;20(6):461-468.e2. doi: 10.1016/j.cllc.2019.05.015. Epub 2019 Jul 4.

PMID:
31377143
3.

Prognostic factors and patterns of failure in advanced stage Hodgkin lymphoma treated with combined modality therapy.

Moding EJ, Advani R, Rosenberg SA, Hoppe RT.

Radiother Oncol. 2018 Dec;129(3):507-512. doi: 10.1016/j.radonc.2018.06.033. Epub 2018 Jul 6.

PMID:
30539763
4.

The impact of postoperative therapy on primary cardiac sarcoma.

Wu Y, Million L, Moding EJ, Scott G, Berry M, Ganjoo KN.

J Thorac Cardiovasc Surg. 2018 Dec;156(6):2194-2203. doi: 10.1016/j.jtcvs.2018.04.127. Epub 2018 Jun 6.

PMID:
30454911
5.

Notch-Induced Myeloid Reprogramming in Spontaneous Pancreatic Ductal Adenocarcinoma by Dual Genetic Targeting.

Cheung PF, Neff F, Neander C, Bazarna A, Savvatakis K, Liffers ST, Althoff K, Lee CL, Moding EJ, Kirsch DG, Saur D, Bazhin AV, Trajkovic-Arsic M, Heikenwalder MF, Siveke JT.

Cancer Res. 2018 Sep 1;78(17):4997-5010. doi: 10.1158/0008-5472.CAN-18-0052. Epub 2018 May 29.

6.

Circulating tumor DNA testing in advanced non-small cell lung cancer.

Moding EJ, Diehn M, Wakelee HA.

Lung Cancer. 2018 May;119:42-47. doi: 10.1016/j.lungcan.2018.02.019. Epub 2018 Mar 2. Review.

PMID:
29656751
7.

Mice Lacking RIP3 Kinase are not Protected from Acute Radiation Syndrome.

Castle KD, Daniel AR, Moding EJ, Luo L, Lee CL, Kirsch DG.

Radiat Res. 2018 Jun;189(6):627-633. doi: 10.1667/RR15001.1. Epub 2018 Apr 10.

8.

Survival impact of postoperative radiotherapy timing in pediatric and adolescent medulloblastoma.

Chin AL, Moding EJ, Donaldson SS, Gibbs IC, Soltys SG, Hiniker SM, Pollom EL.

Neuro Oncol. 2018 Jul 5;20(8):1133-1141. doi: 10.1093/neuonc/noy001.

9.

Concurrent Imatinib and Radiation Therapy for Unresectable and Symptomatic Desmoid Tumors.

Moding EJ, Million L, Avedian R, Ghanouni P, Kunder C, Ganjoo KN.

Sarcoma. 2017;2017:2316839. doi: 10.1155/2017/2316839. Epub 2017 Jul 5.

10.

An extra copy of p53 suppresses development of spontaneous Kras-driven but not radiation-induced cancer.

Moding EJ, Min HD, Castle KD, Ali M, Woodlief L, Williams N, Ma Y, Kim Y, Lee CL, Kirsch DG.

JCI Insight. 2016 Jul 7;1(10). pii: e86698.

11.

Opportunities for Radiosensitization in the Stereotactic Body Radiation Therapy (SBRT) Era.

Moding EJ, Mowery YM, Kirsch DG.

Cancer J. 2016 Jul-Aug;22(4):267-73. doi: 10.1097/PPO.0000000000000203. Review.

12.

Acute DNA damage activates the tumour suppressor p53 to promote radiation-induced lymphoma.

Lee CL, Castle KD, Moding EJ, Blum JM, Williams N, Luo L, Ma Y, Borst LB, Kim Y, Kirsch DG.

Nat Commun. 2015 Sep 24;6:8477. doi: 10.1038/ncomms9477.

13.

A Plasmonic Gold Nanostar Theranostic Probe for In Vivo Tumor Imaging and Photothermal Therapy.

Liu Y, Ashton JR, Moding EJ, Yuan H, Register JK, Fales AM, Choi J, Whitley MJ, Zhao X, Qi Y, Ma Y, Vaidyanathan G, Zalutsky MR, Kirsch DG, Badea CT, Vo-Dinh T.

Theranostics. 2015 May 23;5(9):946-60. doi: 10.7150/thno.11974. eCollection 2015.

14.

Tumor cells, but not endothelial cells, mediate eradication of primary sarcomas by stereotactic body radiation therapy.

Moding EJ, Castle KD, Perez BA, Oh P, Min HD, Norris H, Ma Y, Cardona DM, Lee CL, Kirsch DG.

Sci Transl Med. 2015 Mar 11;7(278):278ra34. doi: 10.1126/scitranslmed.aaa4214.

15.

A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancer.

Sch├Ânhuber N, Seidler B, Schuck K, Veltkamp C, Schachtler C, Zukowska M, Eser S, Feyerabend TB, Paul MC, Eser P, Klein S, Lowy AM, Banerjee R, Yang F, Lee CL, Moding EJ, Kirsch DG, Scheideler A, Alessi DR, Varela I, Bradley A, Kind A, Schnieke AE, Rodewald HR, Rad R, Schmid RM, Schneider G, Saur D.

Nat Med. 2014 Nov;20(11):1340-1347. doi: 10.1038/nm.3646. Epub 2014 Oct 19. Erratum in: Nat Med. 2015 Apr;21(4):414.

16.

Atm deletion with dual recombinase technology preferentially radiosensitizes tumor endothelium.

Moding EJ, Lee CL, Castle KD, Oh P, Mao L, Zha S, Min HD, Ma Y, Das S, Kirsch DG.

J Clin Invest. 2014 Aug;124(8):3325-38. doi: 10.1172/JCI73932. Epub 2014 Jul 18.

17.

Reining in radiation injury: HIF2╬▒ in the gut.

Lee CL, Moding EJ, Kirsch DG.

Sci Transl Med. 2014 May 14;6(236):236fs20. doi: 10.1126/scitranslmed.3009155.

PMID:
24828075
18.

Dual-energy micro-CT functional imaging of primary lung cancer in mice using gold and iodine nanoparticle contrast agents: a validation study.

Ashton JR, Clark DP, Moding EJ, Ghaghada K, Kirsch DG, West JL, Badea CT.

PLoS One. 2014 Feb 10;9(2):e88129. doi: 10.1371/journal.pone.0088129. eCollection 2014.

19.

Strategies for optimizing the response of cancer and normal tissues to radiation.

Moding EJ, Kastan MB, Kirsch DG.

Nat Rev Drug Discov. 2013 Jul;12(7):526-42. doi: 10.1038/nrd4003. Review.

20.

In vivo characterization of tumor vasculature using iodine and gold nanoparticles and dual energy micro-CT.

Clark DP, Ghaghada K, Moding EJ, Kirsch DG, Badea CT.

Phys Med Biol. 2013 Mar 21;58(6):1683-704. doi: 10.1088/0031-9155/58/6/1683. Epub 2013 Feb 19.

21.

A comparison of radial keyhole strategies for high spatial and temporal resolution 4D contrast-enhanced MRI in small animal tumor models.

Subashi E, Moding EJ, Cofer GP, MacFall JR, Kirsch DG, Qi Y, Johnson GA.

Med Phys. 2013 Feb;40(2):022304. doi: 10.1118/1.4774050.

22.

Dual-energy micro-computed tomography imaging of radiation-induced vascular changes in primary mouse sarcomas.

Moding EJ, Clark DP, Qi Y, Li Y, Ma Y, Ghaghada K, Johnson GA, Kirsch DG, Badea CT.

Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1353-9. doi: 10.1016/j.ijrobp.2012.09.027. Epub 2012 Nov 1.

23.

p53 functions in endothelial cells to prevent radiation-induced myocardial injury in mice.

Lee CL, Moding EJ, Cuneo KC, Li Y, Sullivan JM, Mao L, Washington I, Jeffords LB, Rodrigues RC, Ma Y, Das S, Kontos CD, Kim Y, Rockman HA, Kirsch DG.

Sci Signal. 2012 Jul 24;5(234):ra52. doi: 10.1126/scisignal.2002918.

24.

Generation of primary tumors with Flp recombinase in FRT-flanked p53 mice.

Lee CL, Moding EJ, Huang X, Li Y, Woodlief LZ, Rodrigues RC, Ma Y, Kirsch DG.

Dis Model Mech. 2012 May;5(3):397-402. doi: 10.1242/dmm.009084. Epub 2011 Dec 22.

Supplemental Content

Loading ...
Support Center